Afghanistan–Pakistan retinoblastoma “Silk Road” referral pathway

Mattan Arazi ; Jonathan Kfir ; Sayed Mansoor Sediqi ; Abdul Rahim Majeed ; Shabana Chaudhry ; Alona Baum ; Samina Behjat ; Syed Ahmer Hamid ; Allen Foster ORCID logo ; Ido Didi Fabian ORCID logo ; (2025) Afghanistan–Pakistan retinoblastoma “Silk Road” referral pathway. Eye (London, England). ISSN 0950-222X DOI: 10.1038/s41433-025-03823-0 (In Press)
Copy

Background/objectives: There is no specialist retinoblastoma (Rb) treatment centre in Afghanistan. We aimed to describe the first-year experience and outcome of referring Afghani children with Rb to Pakistan for treatment via the Afghanistan-Pakistan Rb "Silk-Road" referral pathway. Methods: A 12-month prospective analysis (January 2023-January 2024) was conducted on children with suspected Rb presenting at National Organisation for Ophthalmic Rehabilitation (NOOR) eye care centres. Online consultations with specialists from the Rb-NET were used to confirm Rb diagnoses, and eligible patients were identified for referral to Rb treatment centres in Pakistan. Data on clinical presentation and outcomes were recorded using a structured Microsoft Excel spreadsheet, which was monitored by the entire team to ensure accuracy and completeness. The primary outcomes included successful transfer to Rb treatment centres in Pakistan and child survival at 1-year follow-up. Secondary outcomes focused on identifying barriers to successful patient transfer. Results: Of the 23 children included in the study, 12/23 (52%) were referred due to leukocoria, 11/23 (48%) were female, 7/23 (30%) presented with bilateral Rb, and none had familial Rb. Overall, 5/23 (22%) children were diagnosed with extraocular disease, and 6/23 (26%) had distant metastases at the time of diagnosis. Only 9/23 (39%) children successfully reached Rb treatment centres in Pakistan. At the last follow-up, 5/23 (22%) children had died, 6/23 (26%) were confirmed alive, and 12/23 (52%) were lost to follow-up. The most common obstacles to patient transfer included difficulty crossing the Afghani/Pakistani border (12/23; 52%) and economic barriers (11/23; 48%) throughout the referral process. Conclusions: This report highlights the immense difficulties in improving child survival from a treatable childhood cancer in a country with poor health care systems. The first-year experience of this referral pathway offers valuable lessons, which can guide the creation of a dedicated Rb treatment centre within Afghanistan.

visibility_off picture_as_pdf

picture_as_pdf
Arazi-etal-2025-Afghanistan–Pakistan-retinoblastoma.pdf
subject
Published Version
lock
Restricted to Repository staff only
Available under Creative Commons: Attribution 4.0

Request Copy
visibility_off picture_as_pdf

Published Version
lock
visibility_off picture_as_pdf

Published Version
lock

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL Data Cite XML EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads